Sign in
Taking people in United StatesPhase 2

Metformin in Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms

Key facts

Who runs it
University of California, Irvine
Where
Orange, United StatesSee the site
Trial code
Status
Recruiting
Phase
Phase 2
People taking part
15 people, planned
Started
18 Jun 2026
Expected to end
Jul 2029
Type of study
Interventional
Treatments tested
  • Metformin
Record updated
13 July 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (6)Hide the full registry criteria

Who can take part

  • Patients with clinical diagnosis of pseudomyxoma peritonei (PMP) secondary to presumed appendiceal mucinous neoplasms (AMNs) with recurrent/refractory disease s/p cytoreductive surgery(CRS)/hyperthermic intraperitoneal chemotherapy (HIPEC), unresectable disease, or without planned CRS/HIPEC
  • Age ≥18 years
  • ECOG performance status ≤2

Who cannot take part

  • Patients currently taking metformin for another medical indication
  • Patients with a prior adverse event to administration of metformin
  • Patients with a clinical diagnosis of PMP secondary to presumed AMNs with resectable disease who are planned to undergo CRS/HIPEC

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age
  • Appendiceal mucinous neoplasm or pseudomyxoma peritonei

This trial is currently available in United States.

  • Chao Family Comprehensive Cancer Center, University of California, IrvineOrange, United StatesContact: Oliver Eng, MDTaking people

About the trial

What the trial wants to find out

This is a pilot, open-label clinical trial determining the feasibility of metformin therapy in subjects with pseudomyxoma peritonei (PMP) secondary to appendiceal mucinous neoplasms (AMNs).

The group in the trial

  • Metformin TreatmentTreatment being tested

    850mg PO daily

    Treatment: Metformin

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Use of Metformin in Patients With Pseudomyxoma Peritonei Secondary to Appendiceal Mucinous Neoplasms
Criteria questions
Built from NCT07693452, who can take part
Record updated
13 July 2026